Skip to main content
SpringerLink
Log in

Atemanaleptica

  • Chapter
Pharmakotherapie bronchopulmonaler Erkrankungen

  • 95 Accesses

Zusammenfassung

Atemanaleptica dienen zur Stimulation bestimmter Abschnitte des zentralen Nervensystems, hier vor allem der Atem-, aber auch der Vasomotoren-Zentren in der Medulla oblongata. Werden sie in höheren Dosen appliziert, können sie krampfauslösend wirken.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. . Bardsley PA, Howard P, DeBacker W, Ver- meire P, Mairesse M, Ledent C (1991) Two years treatment with almitrine bismesylate in patients with hypocic chronic obstructive airways disease. Eur Respir J 4: 308 – 310

    PubMed  CAS  Google Scholar 

  2. . Bisgard GE (1980) The response of few-fiber carotid chemoreceptor preparations to almitrine in the dog. Can J Physiol Pharmacol 59: 396 – 401

    Article  Google Scholar 

  3. . Castaing Y, Manier G, Varene N, Guenard H (1981) Almitrine orale et distribution des rapports VA/Q dans les bronchopneumopathies chroniques obstructives. Bull Europ Physiopath Resp 17: 917 – 932

    CAS  Google Scholar 

  4. . Laubie M, Schmitt H (1980) Long-lasting hyperventilation induced by almitrine: evidence for a specific effect on carotid and thoracic chemoreceptors. Europ J Pharmacol 61: 125 – 136

    Article  CAS  Google Scholar 

  5. . Melot Ch, Naeije R, Rothschild T, Mertens P, Mols P, Hallemanns R (1983) Improvement in ventilation-perfusion matching by almitrine in COPD. Chest 83: 528 – 533

    Article  PubMed  CAS  Google Scholar 

  6. . Mutschler E (1986) Arzneimittelwirkungen. Wissenschaftliche Verlags-Gesellschaft Stuttgart, Stuttgart

    Google Scholar 

  7. . Naeije R, Melot Ch, Hallemanns R, Naeije N, Cornil A, Sergysels R (1981) Effects of almitrine in decompensated chronic respiratory disease. Bull Europ Physiopath Resp 17: 153 – 161

    CAS  Google Scholar 

  8. . Nowak D, Wywiol A, Magnussen H (1998) Almitrin in der Therapie chronisch-obstruk- tiver Atemwegserkrankungen mit Hypoxamie - eine klinische Multicenter-Studie zum Vergleich zweier Dosierungen. Pneumologie 52: 121 – 127

    PubMed  CAS  Google Scholar 

  9. . Paramelle B, Levy P, Pirotte C (1983) Long- term follow-up of pulmonary arterial pressure evolution in COPD patients treated by almitrine bismesylate. Eur J Respir Dis [Suppl] 126: 333 – 336

    Google Scholar 

  10. . Prefaut Ch, Bourgouin-Karaouni D, Ramonato M, Michel FB (1984) One year hemodynamic double blind study in COPD patients treated by almitrine bismesylate. Internat Symp „Lungenkreislauf IV“, Prag

    Google Scholar 

  11. . Romaldini H, Rodriguez-Roisin R, Wagner PD, West JB (1983) Enhancement of hypoxic pulmonary vasoconstriction by almitrine in the dog. Am Rev Respir Dis 128: 288 – 293

    PubMed  CAS  Google Scholar 

  12. . Ruhle KH, Klein G, Giessen S, Costabel U, Matthys H (1984) Der Einflufc eines Atem- analepticums auf die kapillär und transcutan gemessenen Blutgase bei Patienten mit respi- ratorischer Globalinsuffizienz unter Sauer- stoffatmung. Prax Klin Pneumol 38, p 62

    PubMed  CAS  Google Scholar 

  13. . Ruhle KH, Kempf P, Mössinger B, Klein G, Costabel U, Wurtemberger G, Matthys H (1988) Einfluß von Almitrin, einem Chemorezeptorenstimulator, auf die nächtliche Hyperkapnie und den pulmonalarteriellen Druck unter 02-Atmung bei chronisch obstruktiver Lungenerkrankung. Prax Klin Pneumol 42: 411 – 414

    PubMed  Google Scholar 

  14. . Stanley NN, Galloway JM, Flint KC, Campbell DB (1983) Increased respiratory chemosensitivity induced by oral almitrine in healthy man. Br J Dis Chest 77: 136 – 146

    Article  PubMed  CAS  Google Scholar 

  15. . Watanabe S, Kanner RE, Cutillo AG, Menlove RL, Bachand RT, Szalkowski MB, Renzetti AD (1989) Long-term effect of almitrine bysmesylate in patients with hypoxemic chronic obstructive pulmonary disease. Am Rev Respir Dis 140: 1269 – 1273

    PubMed  CAS  Google Scholar 

  16. . Weitzenblum E, Ehrhardt M, Schneider JC, Hirth C, Roegel E (1982) Effects hemodynamiques pulmonaries de l’almitrine intraveineuse chez les bronchiteux chroniques insuffisants respiratoires. Bull Europ Physiopath Resp 18: 765 – 774

    CAS  Google Scholar 

  17. . Winkelmann BR, Kullmer TH, Kneissl DG, Trenk D, Kronenberger H (1994) Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease. Chest 105: 1383 – 1391

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. K.-H. Rüble
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Wilhelminenspital der Stadt Wien, Wien, Österreich

    Friedrich Kummer

  2. Ruhrlandklinik, Essen, Deutschland

    Nikolaus Konietzko

  3. Universitätsspital, Zürich, Schweiz

    Tullio C. Medici

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag/Wien

About this chapter

Cite this chapter

Rüble, KH. (2000). Atemanaleptica. In: Kummer, F., Konietzko, N., Medici, T.C. (eds) Pharmakotherapie bronchopulmonaler Erkrankungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6761-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6761-8_25

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7404-3

  • Online ISBN: 978-3-7091-6761-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation